| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1277.3B | ¥1157.0B | +10.4% |
| Operating Income | ¥261.1B | ¥197.5B | +32.2% |
| Ordinary Income | ¥262.5B | ¥199.4B | +31.6% |
| Net Income | ¥180.0B | ¥139.8B | +28.9% |
| ROE | 13.8% | 11.5% | - |
FY2025 Q3 cumulative results show robust performance with revenue of 127.73 billion yen (YoY +10.4%), operating income of 26.11 billion yen (YoY +32.2%), ordinary income of 26.25 billion yen (YoY +31.6%), and net income of 18.00 billion yen (YoY +28.9%). Operating margin expanded significantly to 20.4% from 17.1% in the prior year, while net profit margin improved to 14.1%. The company's full-year forecast projects revenue of 175.0 billion yen (+7.2% YoY), operating income of 36.0 billion yen (+15.7% YoY), and net income of 27.0 billion yen. EPS reached 391.51 yen for the nine-month period against a full-year forecast of 587.28 yen, indicating solid progress toward annual targets. The company maintains its dividend forecast of 95 yen per share, implying a calculated payout ratio of 41.2% based on current earnings trajectory.
[Profitability] ROE of 13.8% reflects improvement in profitability metrics, with net profit margin of 14.1% and operating margin of 20.4% representing substantial year-over-year expansion. The DuPont analysis reveals ROE composition of net profit margin 14.1%, asset turnover 0.617, and financial leverage 1.58x, with margin expansion being the primary driver of ROE improvement. Operating margin of 20.4% increased 3.3 percentage points from 17.1% in the prior year, indicating strong operating leverage effects as revenue grew 10.4% while operating income surged 32.2%. ROA stands at 8.7%, demonstrating effective asset utilization relative to profitability generation. Interest coverage ratio of approximately 129.9x indicates minimal financial cost burden with interest burden coefficient of 1.010. [Cash Quality] Cash and deposits totaled 22.07 billion yen, providing 0.89x coverage of short-term debt of 24.74 billion yen. Working capital efficiency shows extended cycles with DSO of 211 days, DIO of 160 days, and cash conversion cycle of 287 days, indicating significant capital tied up in operations. Work-in-progress inventory reached 21.95 billion yen, representing 61.2% of total inventory, suggesting project-based production characteristics with extended manufacturing timelines. [Investment Efficiency] Asset turnover ratio of 0.617 reflects moderate asset utilization intensity. Receivables represent 35.7% of total assets at 73.91 billion yen, indicating substantial working capital requirements typical of project-based business models. [Financial Health] Equity ratio of 63.1% demonstrates solid capitalization with total equity of 130.74 billion yen against total assets of 207.15 billion yen. Current ratio of 273.8% and quick ratio of 260.0% suggest strong liquidity on the surface, though short-term debt represents 77.9% of total liabilities. Debt-to-equity ratio of 0.24 and net debt-to-capital ratio of 19.5% indicate conservative leverage with total interest-bearing debt of 31.74 billion yen.
Cash and deposits increased 31.7% year-over-year to 22.07 billion yen from 16.75 billion yen, reflecting operational profit growth contributing to liquidity accumulation. The balance sheet reveals significant working capital expansion with accounts receivable increasing to 73.91 billion yen and inventory rising to 35.88 billion yen, together representing substantial cash absorption in operating cycle. Work-in-progress inventory specifically increased to 21.95 billion yen, indicating ongoing project execution requiring upfront capital deployment. Short-term borrowings increased 31.0% to 24.74 billion yen from 18.88 billion yen, suggesting the company utilized debt financing to support working capital needs and maintain cash reserves. Long-term borrowings also expanded significantly by 90.2% to 7.00 billion yen from 3.68 billion yen, indicating strategic long-term debt issuance. The cash coverage ratio of 0.89x against short-term liabilities indicates adequate but not excessive liquidity cushion, with refinancing considerations warranted given the 77.9% short-term liability concentration. Working capital management shows accounts payable at 88.97 billion yen, representing effective supplier credit utilization at 84 days payable turnover. The extended receivables collection period of 211 days combined with 160 days inventory holding period results in a 287-day cash conversion cycle, substantially longer than typical manufacturing cycles, reflecting project-based revenue recognition and customer payment terms characteristic of the water treatment engineering business.
Ordinary income of 26.25 billion yen compared to operating income of 26.11 billion yen shows minimal non-operating net contribution of approximately 0.14 billion yen, indicating earnings are predominantly driven by core operations. Non-operating income composition includes foreign exchange gains of 0.80 billion yen and investment securities sales gains of 0.88 billion yen, collectively representing approximately 0.64% of revenue at 0.82 billion yen total non-operating income. Non-operating expenses of 0.68 billion yen include interest expenses of 0.20 billion yen, resulting in net financial costs that are immaterial relative to operating profitability. The company recorded extraordinary gains of 1.24 billion yen primarily from investment securities sales, offset by extraordinary losses of 0.93 billion yen, yielding net extraordinary income of 0.31 billion yen or approximately 1.2% of pretax income. The sustainability of earnings quality centers on core operating performance, as non-recurring items represent modest contributions. The substantial improvement in operating margin from 17.1% to 20.4% suggests either favorable project mix, improved execution efficiency, or fixed cost leverage, warranting examination of underlying margin drivers. The extended cash conversion cycle of 287 days relative to strong reported profitability raises questions about cash realization timing, though quarterly cash flow statement data is not disclosed for direct verification. Accruals assessment based on balance sheet changes shows significant working capital buildup in receivables and inventory, suggesting timing differences between revenue recognition and cash collection that are typical in project-based engineering businesses but require monitoring for collection risk and project completion risk.
Working capital concentration risk emerges from the 287-day cash conversion cycle with DSO of 211 days and DIO of 160 days, indicating substantial capital tied up in receivables and work-in-progress inventory totaling 95.86 billion yen or 46.3% of total assets. Extended collection cycles expose the company to customer credit risk and project completion risk, where delays in milestone achievements or customer financial difficulties could impair cash realization and potentially require inventory writedowns or bad debt provisions. Short-term refinancing risk arises from the 77.9% concentration of liabilities in current obligations with short-term borrowings of 24.74 billion yen providing only 0.89x coverage by cash reserves, creating vulnerability to credit market conditions and banking relationship continuity. While interest coverage of 129.9x indicates ample debt service capacity, the maturity structure requires continuous rollover of short-term facilities, and any tightening of credit conditions could compress liquidity. Project execution and profitability risk relates to the 61.2% work-in-progress inventory ratio and extended production cycles, where cost overruns, technical delays, or specification changes in large engineering projects could materially impact margins. The substantial margin expansion to 20.4% suggests favorable current project mix, but sustainability depends on maintaining pricing discipline and execution efficiency across a pipeline where individual project outcomes can significantly impact quarterly results.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of 20.4% substantially exceeds the manufacturing industry median of 8.3% (IQR: 4.8-12.6%), positioning the company in the top quartile for operational efficiency. Net profit margin of 14.1% similarly outperforms the industry median of 6.3% (IQR: 3.2-9.0%), reflecting strong pricing power and cost management. ROE of 13.8% significantly exceeds the industry median of 5.0% (IQR: 2.9-8.1%), indicating superior shareholder value generation. ROA of 8.7% substantially outperforms the industry median of 3.3% (IQR: 1.8-5.2%).
Financial Health: Equity ratio of 63.1% is comparable to the industry median of 63.8% (IQR: 49.5-74.7%), demonstrating alignment with industry capitalization norms. Current ratio of 273.8% is slightly below the industry median of 284.0% (IQR: 210.0-381.0%), though remaining within healthy range.
Efficiency: Asset turnover of 0.617 aligns closely with the industry median of 0.58 (IQR: 0.42-0.66), suggesting comparable asset intensity. However, receivables turnover of 211 days significantly exceeds the industry median of 83 days (IQR: 68-115 days), indicating extended collection cycles specific to project-based business model. Inventory turnover of 160 days also exceeds the industry median of 109 days (IQR: 50-155 days), reflecting work-in-progress intensive operations. Operating working capital cycle of 287 days far exceeds the industry median of 108 days (IQR: 72-143 days), representing the most significant deviation from industry norms and highlighting working capital management as a key differentiator.
Growth: Revenue growth of 10.4% substantially outperforms the industry median of 2.7% (IQR: -1.9% to 7.9%), positioning the company among top-tier growth performers in the manufacturing sector.
Note: Industry benchmarks represent manufacturing sector (98 companies for most metrics), comparison based on 2025-Q3 fiscal periods, source: Proprietary analysis.
Exceptional profitability with operating margin sustainability question: The company demonstrates best-in-class profitability metrics with operating margin of 20.4% and net profit margin of 14.1%, both substantially exceeding industry medians of 8.3% and 6.3% respectively, while revenue growth of 10.4% significantly outpaces the industry median of 2.7%. This combination of high margins and above-average growth positions the company favorably within the manufacturing sector. However, the sustainability of this margin profile warrants attention given the project-based nature of the business, where individual contract profitability can vary significantly. The substantial year-over-year margin expansion of 3.3 percentage points suggests either a particularly favorable current project mix or operational improvements that require validation across future project cycles.
Working capital intensity as distinctive characteristic requiring monitoring: The 287-day cash conversion cycle represents a substantial deviation from the manufacturing industry median of 108 days, with receivables collection of 211 days (versus industry median 83 days) and inventory holding of 160 days (versus industry median 109 days) reflecting the project-based engineering business model. This working capital structure ties up 95.86 billion yen or 46.3% of total assets in receivables and inventory, creating significant capital requirements and cash-earnings divergence typical of engineering, procurement, and construction businesses. While this is intrinsic to the business model, the 77.9% short-term liability concentration with 0.89x cash coverage indicates that working capital efficiency and collection execution are critical operational priorities. The extended cycles also mean that earnings quality and dividend sustainability ultimately depend on successful project completion and customer payment realization rather than reported accounting profits alone.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.